Litcius/Paper detail

Baicalin suppresses the migration and invasion of breast cancer cells via the TGF-β/lncRNA-MALAT1/miR-200c signaling pathway

Jiafeng Li, Huixin Liu, Qiwang Lin, Huajiao Chen, Liya Liu, Hongjuan Liao, Ying Cheng, Xiuli Zhang, Zhenlong Wang, Aling Shen, Guolong Chen

2022Medicine21 citationsDOIOpen Access PDF

Abstract

Metastasis is the major cause of death and failure of cancer chemotherapy in patients with breast cancer (BC). Activation of TGF-β/lncRNA-MALAT1/miR-200c has been reported to play an essential role during the metastasis of BC cells. The present study aimed to validate the suppression of BC-cell migration and invasion by baicalin and explore its regulatory effects on the TGF-β/lncRNA-MALAT1/miR-200c signaling pathway. We found that baicalin treatment inhibited cell viability and migration and invasion. Mechanistically, baicalin treatment significantly downregulated the expression of TGF-β, ZEB1, and N-cadherin and upregulated E-cadherin on both mRNA and protein levels. Additionally, baicalin treatment significantly downregulated the expression of lncRNA-MALAT1 and upregulated that of miR-200c. Collectively, baicalin significantly suppresses cell viability, migration, and invasion of BC cells possibly by regulating the TGF-β/lncRNA-MALAT1/miR-200c pathway.

Topics & Concepts

BaicalinMALAT1Downregulation and upregulationMedicineCancer researchTransforming growth factorViability assayCell migrationSignal transductionMetastasisCellCancerInternal medicineCell biologyBiologyLong non-coding RNAChemistryGeneBiochemistryChromatographyHigh-performance liquid chromatographyCancer-related molecular mechanisms researchFlavonoids in Medical ResearchMedicinal Plant Pharmacodynamics Research